← All Sponsors
SPONSOR

Alfred Chung, MD

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Multiple MyelomaRefractory Multiple MyelomaRelapsed Multiple Myeloma
NCT06348108 Phase 1
Recruiting

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
United States View Trial →